An oncology drug discovery and reprofiling company
Oncolodyne is a pre-clinical and clinical stage drug discovery company focused on reprofiling drugs for cancer therapy.
Our mission is to discover, test and trial safe, effective, affordable small molecule cancer drugs.
This drug reprofiling or repurposing strategy offers significant advantages over conventional drug development approach: Cost effective development, existing epidemiological and population level knowledge, known side effects and a fast track to clinical trials. Our drug discovery pipeline is deeply rooted in biological and epidemiological evidence and validated in robust electrophysiological, intracellular and in vivo models.
Our drug discovery platform is unique as it covers discovery of novel biological mechanisms to clinical translation, including clinical trial readiness and execution.
